MedTrace Logo

Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways

NCT05181111 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2022-01-06

No results posted yet for this study

Summary

Hospitals aim to hospitalize patients when necessary and discharge patients when possible. However, the triage process and discharge management of patients in e.g. the Acute Admission Ward, is not a trivial task. The upcoming technology of wearable monitoring devices, whereby patients can be continuously monitored with an unobtrusive vital signs device, might help getting more insight into patients' health condition and thus help facilitate efficient and effective triaging.

Therefore, the primary objective is to assess the effects of continuous monitoring of patients in the acute admission ward (AAW) on the percentage of patients who can be discharged home. Secondary objectives are to assess the length of stay in the acute admission ward and in the in-hospital wards, as well as the effect on admission to the intensive care unit, rapid response team calls and hospital readmission. The predictive value of algorithms applied to the monitoring data combined with other parameters to detect timely deterioration and predict discharge will be assessed. Facilitators and barriers for implementing such a system will be investigated.

Conditions

  • Monitoring
  • Clinical Deterioration
  • Acute Disease

Interventions

DEVICE

Wearable Sensor

The sensor measures vital signs including heart rate and respiratory rate, posture and level of physical activity.

OTHER

Usual Care

Usual Care Monitoring

Sponsors & Collaborators

  • University of Twente

    collaborator OTHER

  • Philips Research Eindhoven

    collaborator UNKNOWN

  • Rijnstate Hospital

    lead OTHER

Principal Investigators

  • Carine JM Doggen, Prof PhD · Rijnstate Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-06
Primary Completion
2022-12-05
Completion
2023-07-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05181111 on ClinicalTrials.gov